MLAB
Mesa Laboratories Inc /Co/Company with tickers: MLAB
CIK
724004
CUSIP
59064R109
Shares Outstanding
5,524,931
13F Activity (30d)
101 filings
98 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $249,130,000 | USD | 2026-03-31 | 10-K | 2026-06-03 |
| Cost of Revenue | $90,860,000 | USD | 2026-03-31 | 10-K | 2026-06-03 |
| Gross Profit | $158,270,000 | USD | 2026-03-31 | 10-K | 2026-06-03 |
| Operating Expenses | $139,759,000 | USD | 2026-03-31 | 10-K | 2026-06-03 |
| Research & Development | $20,308,000 | USD | 2026-03-31 | 10-K | 2026-06-03 |
| Operating Income | $18,511,000 | USD | 2026-03-31 | 10-K | 2026-06-03 |
| Net Income | $6,712,000 | USD | 2026-03-31 | 10-K | 2026-06-03 |
| EPS (Basic) | $1.22 | USD/shares | 2026-03-31 | 10-K | 2026-06-03 |
| EPS (Diluted) | $1.21 | USD/shares | 2026-03-31 | 10-K | 2026-06-03 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| United States | $106,395,000 | $116,615,000 | $116,895,000 |
| Other | $84,859,000 | $99,051,000 | $111,786,000 |
| China | $24,933,000 | $25,312,000 | $20,449,000 |
By Product & Service (USD)
| Component | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Product | $176,796,000 | $198,395,000 | $203,392,000 |
| Service | $39,391,000 | $42,583,000 | $45,738,000 |